AXGN Earnings & Financial Statements
AxoGen, Inc.
$35.63
+$0.49(+1.39%)
46
Overall
40
Value
27
Tech
73
Quality
Market Cap
$2.06B
Volume
986.00K
52W Range
$15.27 - $52.91
Target Price
$53.82
AXGN earnings and financial statements: AxoGen, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
AXGN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $225.21M | $187.34M | $159.01M | $138.58M | $127.36M |
| Cost of revenue | $57.85M | $45.36M | $37.14M | $24.15M | $22.93M |
| Operating income | -$7.85M | -$3.29M | -$21.46M | -$29.71M | -$25.42M |
| EBITDA | $1.51M | $6.97M | -$12.44M | -$22.58M | -$20.89M |
| Net income | -$15.70M | -$9.96M | -$21.72M | -$28.95M | -$26.98M |
| EPS (diluted) | $-0.34 | $-0.23 | $-0.51 | $-0.69 | $-0.65 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $221.69M | $203.73M | $196.83M | $195.39M | $208.02M |
| Total liabilities | $92.84M | $99.82M | $101.16M | $94.39M | $95.47M |
| Shareholders’ equity | $128.85M | $103.91M | $95.67M | $101.00M | $112.55M |
| Cash and equivalents | $35.55M | $27.55M | $31.02M | $15.28M | $32.76M |
| Long-term debt | $48.39M | $47.50M | $46.60M | $45.71M | $44.82M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $812.0K | $4.54M | -$5.72M | -$16.07M | -$13.40M |
| Capital expenditure | -$5.59M | -$4.52M | -$14.92M | -$21.25M | -$28.40M |
| Free cash flow | -$4.78M | $11.0K | -$20.63M | -$37.32M | -$41.80M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AXGN | $35.63 | +1.4% | 986.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |